Improving cervical cancer prevention for HIV-positive women
CAMPO Data Management and Statistical Core
This study is looking for better ways to prevent cervical cancer in women living with HIV in Mexico and Puerto Rico, by trying out new screening tests, exploring the benefits of probiotics for cervical and anal health, and testing a new HPV vaccine, all to help improve their health and well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11177202 on NIH RePORTER |
What this research studies
This research focuses on enhancing cervical cancer prevention strategies specifically for HIV-positive women in Mexico and Puerto Rico. It involves three main studies: testing new screening methods for detecting high-grade cervical lesions, assessing the effects of probiotics on cervical and anal health, and evaluating a novel therapeutic HPV vaccine. The approach includes rigorous data management and statistical analysis to ensure accurate results and effective dissemination of findings. Patients may be involved in clinical trials that aim to improve their health outcomes through innovative treatments and preventive measures.
Who could benefit from this research
Good fit: Ideal candidates for participation are HIV-positive women and men, particularly those at risk for cervical and anal high-grade lesions.
Not a fit: Patients who are not HIV-positive or those without risk factors for cervical or anal lesions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and treatment options for cervical cancer in HIV-positive individuals.
How similar studies have performed: Previous research has shown promise in similar approaches, particularly in improving screening and treatment strategies for cervical cancer in high-risk populations.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Zhang, Li — University of California, San Francisco
- Study coordinator: Zhang, Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.